Frequency of Hypodontia After Chemotherapy in Childhood Cancer Survivors

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study aims to provide information on the frequency of hypodontia in children cancer survivors receiving chemotherapy before 4 years of age.Patients who met the eligibility criteria will be given a structured questionnaire to fill followed by a radiographic examination (dental panorama) for confirmation and standardization of the results.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT01470235` - Hypodontia and Ovarian Cancer	N/A

NCT number	NCT03445026
Study type	Observational
Source	Cairo University
Contact
Status	Recruiting
Phase	N/A
Start date	January 1, 2018
Completion date	January 2019

Frequency of Hypodontia After Chemotherapy in Childhood Cancer Survivors Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms